Clinical trial
Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin…
NCT00281515 · AGO Study Group, Other · Completed
Key facts
| NCT number | NCT00281515 |
|---|---|
| Title | Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer |
| Official title | An Open-label, Multicenter, Randomized Phase II Study to Compare the Effects of Paclitaxel/Carboplatin and Lonafarnib to Those of Paclitaxel/Carboplatin for First-line Treatment of Patients With Epithelial Ovarian Cancer FIGO Stages IIB-IV |
| Lead sponsor | AGO Study Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epithelial Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Lonafarnib |
| Enrollment | 105 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jan 25, 2006 |
| Last update posted | Jun 29, 2012 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: